gracelicy's library 34 articles Export Sort

Hide details

	Ref-1 controls pax-8 DNA-binding activity. [My Copy] Biochem Biophys Res Commun, Vol. 252, No. 1. (9 November 1998), pp. 178-183. by G. Tell, L. Pellizzari, D. Cimarosti, C. Pucillo, G. Damante posted to pax thyroid by gracelicy on 2005-10-22 06:30:16 as
	Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. [My Copy] Proc Natl Acad Sci U S A, Vol. 99, No. 24. (26 November 2002), pp. 15462-15467. by M. P. Postiglione, R. Parlato, A. Rodriguez-Mallon, et al.A. Rosica, P. Mithbaokar, M. Maresca, R. C. Marians, T. F. Davies, M. S. Zannini, M. De Felice, R. Di Lauro posted to pax thyroid by gracelicy on 2005-10-22 04:54:52 as along with 1 person calvin
	Thyroid transcription factor 1 rescues PAX8/p300 synergism impaired by a natural PAX8 paired domain mutation with dominant negative activity. [My Copy] Mol Endocrinol, Vol. 19, No. 7. (July 2005), pp. 1779-1791. by H. Grasberger, U. Ringkananont, P. Lefrancois, M. Abramowicz, G. Vassart, S. Refetoff posted to pax thyroid by gracelicy on 2005-10-22 04:54:04 as
	Effects of Pax8 and TTF-1 thyroid transcription factor gene transfer in hepatoma cells: imaging of functional protein-protein interaction and iodide uptake. [My Copy] J Nucl Med, Vol. 46, No. 5. (May 2005), pp. 831-839. by A. Altmann, R. B. Schulz, G. Glensch, et al.H. Eskerski, S. Zitzmann, M. Eisenhut, U. Haberkorn posted to pax thyroid by gracelicy on 2005-10-22 04:53:16 as
	The paired domain-containing factor Pax8 and the homeodomain-containing factor TTF-1 directly interact and synergistically activate transcription. [My Copy] J Biol Chem, Vol. 278, No. 5. (31 January 2003), pp. 3395-3402. by T. Di Palma, R. Nitsch, A. Mascia, L. Nitsch, R. Di Lauro, M. Zannini posted to pax thyroid by gracelicy on 2005-10-22 04:30:25 as
	Pax 8 expression in primary cultured dog thyrocyte is increased by cyclic AMP. [My Copy] Biochim Biophys Acta, Vol. 1307, No. 1. (3 June 1996), pp. 97-103. by P. Van Renterghem, G. Vassart, D. Christophe posted to camp pax thyroid by gracelicy on 2005-10-22 02:21:00 as
	Determination of functional domains of the human transcription factor PAX8 responsible for its nuclear localization and transactivating potential. [My Copy] Eur J Biochem, Vol. 247, No. 3. (1 August 1997), pp. 860-869. by A. Poleev, O. Okladnova, A. M. Musti, S. Schneider, B. Royer-Pokora, D. Plachov posted to pax by gracelicy on 2005-10-22 02:19:05 as
	p53 genes mutated in the DNA binding site or at a specific COOH-terminal site exert divergent effects on thyroid cell growth and differentiation. [My Copy] Cancer Res, Vol. 58, No. 13. (1 July 1998), pp. 2888-2894. by A. Casamassimi, M. G. Miano, A. Porcellini, et al.G. De Vita, F. de Nigris, M. Zannini, R. Di Lauro, T. Russo, V. E. Avvedimento, A. Fusco posted to p53 pax thyroid by gracelicy on 2005-10-22 02:18:44 as
	A dominant negative CREB (cAMP response element-binding protein) isoform inhibits thyrocyte growth, thyroid-specific gene expression, differentiation, and function. [My Copy] Mol Endocrinol, Vol. 14, No. 9. (September 2000), pp. 1448-1461. by L. Q. Nguyen, P. Kopp, F. Martinson, K. Stanfield, S. I. Roth, J. L. Jameson posted to thyroid camp creb pax by gracelicy on 2005-10-22 02:16:03 as
	RAS oncogene activation induces proliferation in normal human thyroid epithelial cells without loss of differentiation [My Copy] Oncogene, Vol. 19 (2000), pp. 737-744. by Veâ posted to thyroid pax ras by gracelicy on 2005-10-21 03:25:32 as
	The tumor cell and telomerase. [My Copy] Biochemistry (Mosc), Vol. 68, No. 12. (December 2003), pp. 1275-1283. by M. L. Altshuler, S. E. Severin, A. I. Glukhov posted to cancer telomerase by gracelicy on 2005-10-21 02:02:22 as
	Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of beta-catenin. [My Copy] Anticancer Res, Vol. 23, No. 5A. (t 2003), pp. 3575-3584. by T. F. Zhang, S. Q. Yu, L. S. Guan, Z. Y. Wang posted to breast cancer wt1 by gracelicy on 2005-10-21 01:59:22 as
	Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation. [My Copy] Biochem Biophys Res Commun, Vol. 295, No. 4. (26 July 2002), pp. 784-790. by P. Zapata-Benavides, M. Tuna, G. Lopez-Berestein, A. M. Tari posted to breast wt1 by gracelicy on 2005-10-21 01:55:47 as
	Expression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth. [My Copy] Oncogene, Vol. 21, No. 7. (7 February 2002), pp. 1009-1016. by G. B. Silberstein, G. R. Dressler, K. Van Horn posted to breast cancer hormone pax by gracelicy on 2005-10-21 01:55:08 as
	Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. [My Copy] Anticancer Res, Vol. 21, No. 1A. (b 2001), pp. 1-10. by A. Zaia, G. C. Fraizer, L. Piantanelli, G. F. Saunders posted to cancer hormone prostate wt1 by gracelicy on 2005-10-21 01:54:28 as
	Restricted expression of WT1 messenger ribonucleic acid in immature ovarian follicles: uniformity in mammalian and avian species and maintenance during reproductive senescence. [My Copy] Biol Reprod, Vol. 60, No. 2. (February 1999), pp. 365-373. by S. Y. Chun, E. A. McGee, S. Y. Hsu, et al.S. Minami, P. S. LaPolt, H. H. Yao, J. M. Bahr, A. Gougeon, D. W. Schomberg, A. J. Hsueh posted to ovary wt1 by gracelicy on 2005-10-21 01:53:40 as
	Wilms' tumor protein WT1 as an ovarian transcription factor: decreases in expression during follicle development and repression of inhibin-alpha gene promoter. [My Copy] Mol Endocrinol, Vol. 9, No. 10. (October 1995), pp. 1356-1366. by S. Y. Hsu, M. Kubo, S. Y. Chun, F. G. Haluska, D. E. Housman, A. J. Hsueh posted to ovary wt1 by gracelicy on 2005-10-21 01:50:42 as
	Dissecting the role of glucocorticoids on pancreas development. [My Copy] Diabetes, Vol. 53, No. 9. (September 2004), pp. 2322-2329. by E. Gesina, F. Tronche, P. Herrera, et al.B. Duchene, W. Tales, P. Czernichow, B. Breant posted to hormone pancreas pax by gracelicy on 2005-10-21 00:29:00 as
	Survival and proliferation factors of normal and malignant plasma cells. [My Copy] Int J Hematol, Vol. 78, No. 2. (August 2003), pp. 106-113. by B. Klein, K. Tarte, M. Jourdan, et al.K. Mathouk, J. Moreaux, E. Jourdan, E. Legouffe, J. De Vos, J. F. Rossi posted to cancer mapk pax plasma by gracelicy on 2005-10-20 23:47:06 as
	Parathyroid hormone-related protein in human renal cell carcinoma. [My Copy] Cancer Lett (10 October 2005) by Carole Sourbier, Thierry Massfelder posted to cancer hormone renal by gracelicy on 2005-10-20 23:21:47 as
	Breast cancer and ovarian cancer genetics. [My Copy] J Long Term Eff Med Implants, Vol. 15, No. 5. (2005), pp. 533-545. by R. F. Edlich, K. L. Winters, K. Y. Lin posted to breast cancer ovarian by gracelicy on 2005-10-20 23:21:16 as along with 2 people poojamaj srp33
	The biology of steroid hormones and endocrine treatment of breast cancer. [My Copy] Breast (27 September 2005) by Mitch Dowsett, Elizabeth Folkerd, Deborah Doody, Ben Haynes posted to breast cancer hormone by gracelicy on 2005-10-20 23:20:56 as along with 1 person Zephyrus
	Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study. [My Copy] Cancer Epidemiol Biomarkers Prev, Vol. 14, No. 10. (October 2005), pp. 2316-2325. by F. Canzian, J. D. McKay, R. J. Cleveland, et al.L. Dossus, C. Biessy, C. Boillot, S. Rinaldi, M. Llewellyn, V. Chajès, F. Clavel-Chapelon, B. Téhard, J. Chang-Claude, J. Linseisen, P. H. Lahmann, T. Pischon, D. Trichopoulos, A. Trichopoulou, D. Zilis, D. Palli, R. Tumino, P. Vineis, F. Berrino, H. B. Bueno-de-Mesquita, C. H. van Gils, P. H. Peeters, G. Pera, A. Barricarte, M. D. Chirlaque, J. R. Quirós, N. Larrañaga, C. Martínez-García, N. E. Allen, T. J. Key, S. A. Bingham, K. T. Khaw, N. Slimani, T. Norat, E. Riboli, R. Kaaks posted to breast cancer hormone by gracelicy on 2005-10-20 23:20:33 as
	Thyroid hormone receptor beta1 in normal colon and colorectal cancer-association with differentiation, polypoid growth type and K-ras mutations. [My Copy] Int J Cancer (17 October 2005) by Tuomo T T. Hörkkö, Karoliina Tuppurainen, Susannah M M. George, Petra Jernvall, Tuomo J J. Karttunen, Markus J J. Mäkinen posted to cancer colorectal hormone ras by gracelicy on 2005-10-20 23:16:30 as
	Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. [My Copy] Nature, Vol. 387, No. 6631. (22 May 1997), pp. 422-426. by G. Leone, J. DeGregori, R. Sears, L. Jakoi, J. R. Nevins posted to cell_cycle myc ras by gracelicy on 2005-10-20 05:06:51 as along with 1 person catcremona
	Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. [My Copy] Mol Endocrinol, Vol. 19, No. 2. (February 2005), pp. 327-339. by A. Skildum, E. Faivre, C. A. Lange posted to breast cell_cycle hormone mapk by gracelicy on 2005-10-20 04:16:16 as
	Inhibition of proliferation of T47D human breast cancer cells: alterations in progesterone receptor and p53 tumor suppressor protein. [My Copy] Mol Cell Biochem, Vol. 175, No. 1-2. (October 1997), pp. 81-89. by S. Dinda, S. Kodali-Gali, L. Sevilla, M. Burkley, C. Hurd, V. K. Moudgil posted to breast hormone p53 by gracelicy on 2005-10-20 04:15:14 as
	Differential regulation of retinoblastoma protein by hormonal and antihormonal agents in T47D breast cancer cells. [My Copy] J Steroid Biochem Mol Biol, Vol. 77, No. 2-3. (May 2001), pp. 135-141. by P. Alban, C. Hurd, S. Dinda, N. Khattree, V. K. Moudgil posted to breast hormone p53 rb by gracelicy on 2005-10-20 04:11:36 as
	Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line. [My Copy] J Biol Chem, Vol. 270, No. 48. (1 December 1995), pp. 28507-28510. by C. Hurd, N. Khattree, P. Alban, et al.K. Nag, S. C. Jhanwar, S. Dinda, V. K. Moudgil posted to breast cancer hormone p53 by gracelicy on 2005-10-20 04:10:44 as
	Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: impact on proliferation and apoptosis. [My Copy] Kidney Int, Vol. 66, No. 6. (December 2004), pp. 2181-2192. by S. L. Zhang, J. Guo, B. Moini, J. R. Ingelfinger posted to angiotensin hormone kidney pax by gracelicy on 2005-10-20 02:02:30 as along with 1 person yavanna
	Angiotensin II increases Pax-2 expression in fetal kidney cells via the AT2 receptor. [My Copy] J Am Soc Nephrol, Vol. 15, No. 6. (June 2004), pp. 1452-1465. by S. L. Zhang, B. Moini, J. R. Ingelfinger posted to angiotensin hormone kidney pax ras by gracelicy on 2005-10-19 23:50:02 as
	Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. [My Copy] Mol Endocrinol, Vol. 13, No. 6. (June 1999), pp. 829-836. by C. A. Lange, J. K. Richer, K. B. Horwitz posted to breast cancer hormone by gracelicy on 2005-10-19 23:17:13 as
	Apc deficiency predisposes to renal carcinoma in the mouse [My Copy] Oncogene, Vol. aop, No. current. by Owen J. Sansom, David F. R. Griffiths, Karen R. Reed, Douglas J. Winton, Alan R. Clarke, posted to apc cyst by gracelicy on 2005-10-19 23:11:09 as
	Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development [My Copy] Nature (10 July 2005) by Abdolrahman S. Nateri, Bradley Spencer-Dene, Axel Behrens posted to apc jnk tcf4 by gracelicy on 2005-10-19 03:26:28 as

Note: You may cite this page as: http://www.citeulike.org/user/gracelicy

Sort by:
Order:	Default Ascending Descending
Empty fields:	Default First Last

pax	15
hormone	14
cancer	12
breast	11
thyroid	9
wt1	5
p53	4
ras	4
mapk	2
ovary	2
cell_cycle	2
camp	2
kidney	2
apc	2
angiotensin	2
ovarian	1
plasma	1
cyst	1
myc	1
creb	1
tcf4	1
jnk	1
rb	1
pancreas	1
renal	1
colorectal	1
telomerase	1
prostate	1

gracelicy's library 34 articles Export Sort

gracelicy's tags